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A B S T R A C T  29 
This study aimed to investigate the effect of aromatherapy massage on anxiety, depression and physiologic 30 
parameters in older patients with acute coronary syndrome. This randomized controlled trial was conducted on 90 31 
older women with acute coronary syndrome. The participants were randomly assigned into the intervention and 32 
control groups (n=45). The intervention group received reflexology with lavender essential oil, but the control group 33 
only received routine care. Physiologic parameters, the levels of anxiety and depression in the hospital were 34 
evaluated using a checklist and the hospital’s anxiety and depression scale, respectively before and immediately 35 
after the intervention.  36 
Significant differences in the levels of anxiety and depression were reported between the groups after the 37 
intervention. The analysis of physiological parameters revealed a statistically significant reduction (p< 0.05) in 38 
systolic blood pressure, diastolic blood pressure, mean arterial pressure and heart rate. However, no significant 39 
difference was observed in the respiratory rate. Aromatherapy massage can be considered by clinical nurses an 40 
efficient therapy for alleviating psychological and physiological responses among older women suffering from acute 41 
coronary syndrome. 42 
 43 
 44 
Summary statement 45 
What is already known about the topic? 46 
• Depression and anxiety in cardiac care units are often not managed adequately. 47 
• Older adults with acute coronary syndrome may suffer from negative emotions more than other age groups. 48 
What this paper adds? 49 
• This study showed the positive effect of aromatherapy massage on alleviating anxiety and depression among older 50 
women with acute coronary syndrome. 51 
• Aromatherapy massage can be considered a complementary therapy and used along with routine interventions for 52 
relieving psychological and physiological problems among older women hospitalized in cardiac care units. 53 
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1. Introduction 58 
Acute coronary syndrome (ACS) is the type of ischemic heart disease (IHD) in which coronary arteries are 59 
obstructed or closed (Govindaraju, Badruddin et al. 2013). ACS leads to the reduction of the oxygen supply to heart 60 
muscles due to atherosclerosis or coronary artery spasm. Therefore, an increase in the myocardial oxygen demand, 61 
in cases of tachycardia or severe anemia, enhances the vascular injury and finally may lead to ACS (Cho, Min et al. 62 
2013) . 63 
As a major public health issue in developing countries, ACS has become highly prevalent, responsible for about 35 64 
percent of all deaths across the world. In other words, almost one million deaths occur each year due to ACS. 65 
Accordingly, about 40 percent of ACS-related deaths occur in high-income countries with a share of 28 percent in 66 
low to middle-income countries (McKinley, Dracup et al. 2009, Mohammadpur, Mohammadian et al. 2014). ACS is 67 
one of the leading causes of hospitalization in the cardiac care unit (CCU) (Han and Park 2002). Poor functional 68 
statues in the activities of daily livings among patients with ACS result in anxiety and depression (Bauer, Caro et al. 69 
2012).  70 
Anxiety affects the function of the body’s organs and also causes negative health-related consequences in patients 71 
with myocardial infarction (MI) (Huffman, Mastromauro et al. 2011). Moreover, the progression of cardiac ischemia 72 
and even dysrhythmia are the significant negative consequences of anxiety and depression (Huffman, Celano et al. 73 
2010). More than half of these patients report the symptoms of anxiety due to the: 1) unfamiliar hospitalization’s 74 
environment, 2) sudden diagnosis of ACS, 3) isolation from the family, 4)  being encountered with strangers,  5) loss 75 
of individuality and independence, 6) unexpected care routines and 7) critical situations (McKinley, Fien et al. 76 
2012). In addition, these patients encounter many fearful situations such as: 1) life-threatening conditions, 2) the 77 
probability of an additional MI and 3) the fear of the unknowns (Arora, Anand et al. 2010). Such discomforts 78 
accelerate the release of catecholamine and cause physiologic responses such as an increase in the blood pressure 79 
(BP), heart rate (HR), respiratory rate (RR) and dyspnea, possibly exacerbating the development of MI (Frasure-80 
Smith and Lesperance 2008).  81 
The use of medication to relieve anxiety and depression in patients with ACS reduces the level of patients’ alertness 82 
and may cause further health-related complications (de Jong-Watt and Arthur 2004). Therefore, choosing an 83 
appropriate method for alleviating patients’ anxiety and depression without the use of drugs is of great importance 84 
(Rejeh, Heravi-Karimooi et al. 2015). 85 
Currently, more attention is paid to complementary and alternative medicine (CAM) strategies, because they have 86 
fewer complications and are easy to access (Mohammadpur, Mohammadian et al. 2014). These strategies are highly 87 
recommended in older patients with an impaired metabolism and increased sensitivity to the side effects of drugs 88 
(Perković-Vukčević, Vuković-Ercegović et al. 2016). For instance, cognitive and cardiovascular adverse effects 89 
among older people, after the use of tranquilizers and cardiovascular drugs, are very common (Sztramko, Chau et al. 90 
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2011). CAM can help healthcare providers with the management of signs and symptoms related to cardiovascular 91 
disorders including ACS (Greenfield, Pattison et al. 2008). 92 
Aromatherapy is one of the recommended non-pharmacological CAM strategies for symptom management in 93 
hospitalized patients. It is the most widely used complementary therapy in nursing practice and is the therapeutic use 94 
of essential oils extracted from plants and administered through the olfactory system (inhalation) or the skin 95 
(massage) (Buckle 2001, Kyle 2006). 96 
A number of essential oils (lavender, geranium, jasmine, rosemary, rose, evening primrose oil, and chamomile) are 97 
used for relieving psychological symptoms such as anxiety and depression (Taavoni, Darsareh et al. 2013). 98 
Lavender has particularly been used for a long time in traditional medicine with an effect on the central nervous 99 
system leading to the release of encephalin, serotonin and endorphins (Heidari Gorji, Ashrastaghi et al. 2015). 100 
Lavender (Lavandula angustifolia) is widely used in different contexts (Hashemi, Hajbagheri et al. 2015). Previous 101 
studies have confirmed the sedative effects of Lavender on the parasympathetic system. Also, it has been found that 102 
lavender promotes the heart function and coronary blood flow (Bikmoradi, Seifi et al. 2015). Several studies 103 
suggested that aromatherapy and massage had positive effects on physiologic parameter and the level of anxiety and 104 
depression (Edge 2003, Hur, Oh et al. 2007, Chang 2008). Moreover, the risk of hospitalization in the CCU among 105 
older patients is more than other groups of patients (Ancona, Arca et al. 2004).  106 
Therefore, the aim of this study was to investigate the effect of aromatherapy massage on anxiety, depression and 107 
physiological parameters in older patients with ACS. The research hypothesis for this study was as follows: an 108 
aromatherapy massage intervention for older patients with ACS will result in significant differences between an 109 
intervention group and control group in terms of anxiety, depression, systolic blood pressure (SBP), diastolic blood 110 
pressure (DBP), mean arterial pressure (MAP), heart rate (HR) and respiratory rate (RR). 111 
2. Materials and methods 112 
2.1. Aims 113 
The aim of this study was to identify the effect of aromatherapy massage on anxiety, depression and physiologic 114 
parameters in older patients with ACS. 115 
2.2. Design  116 
This was a randomized controlled trial with a pre-intervention–post-intervention design. A convenience sample of 117 
90 older patients were randomly allocated into either the intervention or the control group. They were hospitalized 118 
for one day in the CCU and diagnosed with ACS. The patients in the intervention group received aromatherapy 119 
massage with lavender; those in the control group only received routine care delivered by nurses in the CCU.  120 
2.3. Setting and participants 121 
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This study was conducted in a high turnover CCU of a teaching hospital in Tehran, Iran from July 2014 to 122 
December 2015.  123 
Ninety older women, aged 60 years and over, were chosen using a convenience sampling method. None of the 124 
participants were excluded from the study. As a result, all of them were randomized into either the intervention or 125 
the control groups (n = 45 in each group).  126 
The following inclusion criteria were considered for the recruitment of the participants: 1) diagnosed with ACS; 2) 127 
60 years old and above (the beginning of the old age in developing countries); 3) able to understand and 128 
communicate in Farsi language and follow instructions; 4) not taking any anxiolytics and sedative drugs during the 129 
last four hours before the intervention; 5) not receiving alternative and complementary medicines during the last 48 130 
hours before the intervention; 6) not  having foot ulcers; 7) no history of drug addiction; 8) no history of asthma, 131 
eczema and allergy and 9)  passing the olfactory heath test and the abbreviated mental test (score ≥ 7). 132 
Only female patients with ACS were recruited for this study in order to eliminate any gender influence on the level 133 
of anxiety or depression. The exclusion criteria were: 1) any hemodynamic instability during the intervention; 2) 134 
refusing to complete the intervention session and 3) any allergic reaction to the essential oils or perfumes. It was 135 
noted that no harm or side effects occurred throughout the trial. 136 
 137 
2.4. Sample size 138 
The sample size was determined using a statistical power analysis (α = 0.05, β = 15%, power = 90%, Altman’s 139 
Nomogram). It was also based on a sample size determined in a previous study (Mahmoudirad, Ghaedi Mosolo et al. 140 
2014). 141 
2.5. Randomization 142 
Following receiving the ethical committee’s approval at the university and obtaining the permission to enter the 143 
CCU, the nurse manager in the CCU was informed of the study’s purpose and the selection criteria to help with the 144 
identification of eligible participants. A convenience sample of older women, meeting the inclusion criteria, was 145 
chosen, with no patient declining to participate.  146 
The allocation of the participants to the groups happened during the week that the researcher (TB) visited the 147 
hospital. A system of sealed envelopes was used for the random assignment of the eligible participants into the 148 
groups with each envelope assigned to a specific group. The sampling process continued until a sufficient number of 149 
the participants were recruited into each group (Figure1). It is noted that the second author (NR) generated the 150 
random allocation sequence, the first author (TB) enrolled participants and assigned participants to interventions. It 151 
was impossible to control the participants’ or staffs’ awareness of the group assignment due to the nature of the 152 
intervention (aromatherapy massage) and lavender smell. However, the data analyst (SDT) was unaware of the 153 
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group assignment. In addition, the randomization code was available only to a research fellow who was not 154 
connected to this study. The code was disclosed to the researchers when the statistical data analysis was completed.   155 
2.6. Measurements 156 
The instrumentation for this research included several instruments. These included: 1) personal and medical 157 
information form, 2) measurement of physiological parameters, 3) an abbreviated mental test, and 4) Hospital 158 
Depression and Anxiety Scale (HADS). 159 
2.6.1. The personal and medical information form 160 
The personal and medical information form measured demographic characteristics, including: 1) age, 2) marital 161 
status, 3) employment status, 4) educational level, 5) living status and 6) any history of hospitalization. 162 
2.6.2. Measurement of physiological parameters 163 
The physiological indicators were measured one minute before and after the intervention when the participants were 164 
at rest. These parameters included: 1) SBP, 2) DBP, 3) MAP, 4) HR and 5) RR. These data were extracted from 165 
participants’ charts before and after the intervention. The participants’ blood pressure (BP) was measured on their 166 
left arm using a mercury sphygmomanometer, after they rested for 15 minutes while lying on their back. Instead of a 167 
pulse rate, the participants’ HR was monitored through the monitoring machine. Also, MAP was measured and 168 
reported by this machine. The RR was also measured for one minute without the participants being aware of the 169 
measurement.  170 
2.6.3. Abbreviated Mental Test 171 
 The abbreviated mental test (AMT) rapidly assesses older individuals for the presence of cognitive disorders. Older 172 
individuals, with a score greater than 7 were considered normal. A score lower than 7 out of 10 indicated cognitive 173 
impairment (Faraji, Fallahi khoshknab et al. 2013). The Cronbach's alpha coefficient of the AMT was reported as 174 
0.76 (Bakhtiyari, Foroughan et al. 2014). 175 
2.6.4. Hospital Anxiety and Depression Scale (HADS) 176 
The HAD scale evaluated the levels of anxiety and depression in the participants. The instrument consisted of 14 177 
items, seven for each subscale of anxiety (HADS-A) and depression (HADS-D). The participants rated each item on 178 
a self-rating scale from zero to three. The scoring system ranged from the absence of symptoms (score 0) to the 179 
maximal presentation of symptoms (score 3). Therefore, a higher score indicated a higher level of anxiety or 180 
depression (Zigmond and Snaith. 1983). Correlations between the two subscales varied from 0.40 to 0.74 with a 181 
mean of 0.56. The Cronbach's alpha for the HADS-A varied from 0.68 to 0.93 with a mean of 0.83, while the alpha 182 
for the HADS-D was from 0.67 to 0.90 with a mean 0.82 (Bjelland, Dahl et al. 2002). The reliability and validity of 183 
the Iranian version of the hospital depression and anxiety scale (HADS) was assessed (Montazeri, Harirchi et al. 184 
1999). Also this scale was used in patients with coronary heart diseases in a previous study (Barth and Martin 2005). 185 
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The cut-off score of greater than 8 for the diagnosis of either anxiety or depression was suggested (Stafford, Berk et 186 
al. 2007). The quantitative scoring of both subscales ranged from 0 to 27. Scores greater than or equal to five were 187 
associated with mild anxiety or depression. Scores greater than or equal to ten were associated with moderate 188 
anxiety or depression. Scores greater than or equal to 15 were associated with moderately severe anxiety or 189 
depression, while scores equal to or greater than 20 indicated severe anxiety or depression (Kroenke, Spitzer et al. 190 
2001).  191 
2.7. Intervention 192 
The researcher (TB) explained the study’s purpose, benefits and potential risks to those patients meeting the 193 
inclusion criteria. It should be noted that nursing work patterns and nurse staff remained unchanged throughout the 194 
study process. During the intervention, the researcher applied the aromatherapy massage to participants exactly as 195 
planned. She successfully passed the required training courses with regard to aromatherapy massage under the 196 
supervision of specialists in the field of traditional and complementary medicine. The control group received routine 197 
care delivered by nurses in the CCU, while the participants who were assigned to the intervention group received the 198 
aromatherapy massage intervention in addition to routine care. Routine care was consisted of medication 199 
administration based on physicians’ orders and scheduled nursing interventions delivered to all patients hospitalized 200 
in the CCU.  201 
The intervention was performed in the patient’s bed. The nursing staff or family members were asked not to enter 202 
when the participant was taking part in the study in order to minimize noises and disruptions, and enhance 203 
relaxation. All participants in the intervention group were placed in a supine position and a pillow was placed under 204 
their knees. The intervention and evaluation of its effect were carried out in the evening. 205 
The researcher washed her hands with warm water and applied a moderate amount of almond oil (6 drops) to her 206 
hands. After general foot massage, relaxing techniques included effleurage movements (ten times), stretching 207 
fingers by holding them between thumbs and other fingers (five times in both directions) and moderate rotational 208 
movements around the ankle (five times). The reflex zones of solar plexus, pituitary gland, brain, heart, large and 209 
small intestines, vertebral column, adrenal and kidney were used for the stimulation. The researcher exerted the firm 210 
downward pressure with her thumbs in the above-mentioned areas for: 1) 14 seconds in the solar plexus, 2) 40 211 
seconds in the pituitary gland (5 times), 3) 5 seconds in the brain area, 4) 10 seconds in heart area 5) 5 times for each 212 
intestine and 6) 5 times for the adrenal gland and kidney. The rubbing technique was used for the adrenal and kidney 213 
reflex zones. Prior to, and after the aromatherapy massage intervention, the levels of depression and anxiety in the 214 
hospital, and physiologic parameters were measured. 215 
2.8. Ethical considerations 216 
The institutional review board approval (decree number: 41-228111) was granted by the university in which the 217 
authors worked. All participants signed written informed consent when they were invited to take part in the study. 218 
The ethical consideration of this study conformed to the Declaration of Helsinki 1995, revised 2001. Numbers, 219 
8 
 
8 
 
rather than names were used to de-identify the participants to ensure their confidentiality and anonymity. Since this 220 
intervention used a CAM strategy, no harm was anticipated for the participants. However, this study was carried out 221 
under the supervision and control of a cardiologist in the CCU. No patient withdrew from the study and no harm was 222 
identified as occurring to any participants throughout the study process.   223 
2.9. Data analysis 224 
Statistical analyses were performed using the SPSS version 21.0 software (SPSS Inc., Chicago, IL). After the data 225 
collection, data analysis was performed using descriptive statistics (frequency, percentage, mean and standard 226 
deviation) and inferential statistics (independent t-test, chi-squared test, Cramer’s V test, and Cohen test). The 227 
Kolmogorov-Smirnov test was carried out to examine the normal distribution of the data. The level of statistical 228 
significance was considered p < 0.05.  229 
3. Results 230 
3.1. The demographic characteristics of the participants at the baseline 231 
All 90 older women were eligible for inclusion in this study and were approached. All participants agreed to 232 
participate and fully completed throughout the study process. The independent t-test and chi-square test showed no 233 
statistically significant differences between the two groups in terms of age, marital status, employment status, 234 
educational level, living status, and history of hospitalization (Table 1).  235 
3.2. Hospital Anxiety and Depression Scale scores 236 
The statistical analysis with regard to the level of anxiety demonstrated that, after the intervention, the level of 237 
anxiety was significantly lower in the intervention group (x2 = 12.95, df = 3, p = 0.005) as compared with the 238 
control group. According to the Cramer’s V test, the correlation between the intervention and level of anxiety was 239 
moderate (v2 = 0.379).  240 
The means and standard deviations of anxiety changed from 12.31 ± 5.22 (before the intervention) to 8.04 ± 4.71 241 
(after the intervention) in the intervention group, and from 11.66 ± 4.24 to 11.07 ± 3.19 in the control group. The 242 
effect size for the difference in reported anxiety between the groups was 0.75, demonstrating a large effect size of 243 
the aromatherapy massage intervention (Table 2). 244 
In relation to the participants’ level of depression, a statistical significant difference between the groups was 245 
demonstrated (x2 =16.512, df = 3, p = 0.001). Also, the Cramer’s V test revealed a moderate correlation between the 246 
aromatherapy massage intervention and the level of depression (v2 = 0.428). The means and standard deviations for 247 
depression changed from 12.51 ± 5.40 (before the intervention) to 8.08 ± 4.71 (after the intervention) in the 248 
intervention group, and from 11.71 ± 4.29 to 11.11 ± 3.42 in the control group (Table 2). 249 
3.3. Physiologic parameters 250 
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The comparison of the physiological parameters for the intervention and control groups were shown in Table 3. 251 
There were no statistical significant differences between the groups before the intervention except for RR. While 252 
SBP, DBP, MBP and HR significantly reduced after the intervention, no statistically significant difference was 253 
found in RR in the intervention group after the intervention. The assessment of the Cohen test demonstrated an 254 
average effect size in SBP, DBP, MBP, but a small effect size in HR (Table 3). 255 
4. Discussion  256 
The present study was conducted to investigate the effect of aromatherapy massage on anxiety, depression and 257 
physiological parameters among older women with ACS. After the intervention, aromatherapy massage significantly 258 
improved the levels of anxiety and depression and decreased SBP, DBP, MBP and HR as compared with the 259 
baselines. However, despite a clinical decline in RR, no statistically significant reduction was reported.  260 
Psychological issues, caused by an ACS in older people, can have negative impacts on their lives, and these 261 
additional problems should be managed by health care professionals. Many studies suggested different treatment 262 
modalities for the management of anxiety and depression, and the equilibration of physiologic parameters, but an 263 
interest in the use of complementary and alternative therapies among older patients with heart diseases is increasing 264 
(Sibbritt, Davidson et al. 2015). Various studies have confirmed the efficacy of non-pharmacological measures such 265 
as aromatherapy massage for relieving psychological symptoms in different groups of patients(Cooke and Ernst 266 
2000, Okamoto, Kuriyama et al. 2005), but immediate consequences and benefits of this therapy on the levels of 267 
anxiety and depression are still unknown. 268 
In the present study, most participants reported the initial high levels of anxiety and depression. However, after the 269 
aromatherapy massage intervention, the participants showed statistically significant reductions in their symptoms as 270 
compared with those of the control group. These findings are supported by the findings of previous studies on the 271 
use of essential oil massage for relieving similar symptoms (Wilkinson, Aldridge et al. 1999, Domingos Tda and 272 
Braga 2015). In addition, a recent study examined the impact of aromatherapy massage on psychological parameters 273 
and found that aromatherapy massage also improved patients’ anxiety and depression (Wu, Cui et al. 2014). 274 
According to the findings of this study, aromatherapy massage reduced the psychological symptoms of the 275 
participants. These reductions might be attributed to the relaxant effects of lavender on the autonomic nervous 276 
system with an associated effect on the patient’s emotions. Perry et al. (2006) also emphasized the anti-anxiety 277 
mechanism of the linalool in lavender. Other studies among animals showed that the pharmacologic effect of 278 
lavender was similar to that of diazepam (Umezu 2000, Perry and Perry 2006). In addition, according to one 279 
hypothesis, the use of essential oils may also help reduce the blockage of the olfactory pathways and lead to anti-280 
depressant effects (Yim, Ng et al. 2009, Hongratanaworakit 2011).  281 
In contrast, Koriyama et al (2005) did not report any significant reduction in the anxiety level with a course of 282 
aromatherapy or massage (Kuriyama, Watanabe et al. 2005). Sodden et al. (2004) and Chang et al. (2008) reported a 283 
significant reduction in the level of depression after receiving the treatment in patients with cancer, but the treatment 284 
had no effect on the level of anxiety (Soden, Vincent et al. 2004, Chang 2008). Despite the gradual reduction of 285 
anxiety in patients with breast cancer in the Imanishi et al.’s (2009) study, researchers did not find any statistically 286 
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significant difference in the participants’ level of depression (Stevensen 1994, Imanishi, Kuriyama et al. 2009). 287 
Several factors including type of patients, underlying disorders, the duration and method of intervention, patient’s 288 
psychological conditions or the amount and type of aroma may contribute to the conflicting findings on the effects 289 
of lavender on participants’ psychological symptoms.  290 
As a complex process, aromatherapy massage consists of aroma oil for the olfactory stimulation, and a massage as a 291 
tactile stimulation. This combination therapy may improve participants’ physiologic parameters through the 292 
absorption of the aroma oil by the skin and subsequent stimulation of the olfactory system. This therapeutic remedy 293 
can affect the parasympathetic nervous system, stabilizing the patient’s physiologic parameters and metabolism and, 294 
eventually, maintaining the patient’s level of relaxation (Imura, Misao et al. 2006, Kim and Kim 2012, Eguchi, 295 
Funakubo et al. 2016).  296 
In this study, changes in BP were seen in those participants with reduced anxiety and depression after the 297 
intervention. As other studies also indicated that BP was decreased with the reduction of anxiety, it was believed 298 
that aroma foot massage might reduce BP through reducing the participant’s anxiety (Eguchi, Funakubo et al. 2016). 299 
In addition, other studies also reported the decreased levels of SBP, DBP and MBP after aroma self-foot reflexology 300 
massage (Hur, Oh et al. 2007, Kim and Kim 2012, Bahrami, Rejeh et al. 2016). In contrast, Rho et al. (2006) stated 301 
that aromatherapy massage had no statistically significant differences in BP and HR between the two groups (Rho, 302 
Han et al. 2006). 303 
Complementary medicine experts believe that during, and immediately after the intervention, some changes in the 304 
HR, RR or temperature may be created. Therefore, such interventions should be provided in more than one session 305 
to be able to assess and document its benefits (Gunnarsdottir and Jonsdottir 2010). This phenomenon, known as a 306 
cleansing process, can be the reason for the lack of changes in RR in this study. Unlike our findings Stevenson and 307 
Chang believe that respiratory rate decrease as an immediate effect of massage with the essential oil (Stevensen 308 
1994, Chang 2008). Also Domingos et al. (2015) stated that the application of a mixture of essential oils through 309 
massage in children with first-degree burns made a significant decrease in the HR and RR (Domingos Tda and 310 
Braga 2015). 311 
This study has several strengths. The researchers evaluated the effects of complementary therapies in older women 312 
as a neglected area of research in relation to complementary therapy. This was also the first study to examine the 313 
effect of aromatherapy massage in patients with ACS. Furthermore, studies on the biological outcomes following 314 
aromatherapy massage have been very limited. This study was conducted in one hospital with a group of 315 
homogeneous participants to prevent any threat to the generalization of the findings. However, further studies in 316 
other hospitals with a larger sample size from both genders are suggested.  317 
 318 
Limitations and recommendation for future research of the study 319 
Although this research demonstrated that aromatherapy massage can have beneficial effects on psychological and 320 
physiological symptoms, a lack of long-term massage and follow up may have limited the full effect of the 321 
intervention.  322 
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Another challenge was the inability to distinguish the effects of aromatherapy from the effects of massage. 323 
However, the researchers hypothesized that a combination of aroma oil and massage might have increased the 324 
effectiveness of the intervention. Therefore, future studies focusing on the comparison of massage with and without 325 
essential oils are suggested. Also, it is recommended to continue the aromatherapy massage for at least one month. 326 
Further studies on the application of aromatherapy massage in the CCU are also proposed to investigate its effect 327 
concerning patients’ sedation levels and address the above-mentioned limitations. Contradictions in physiologic 328 
parameters in different studies warrant the necessity of further examination of the effect of aromatherapy massage. 329 
On the other hand, if the effectiveness of aromatherapy massage are confirmed in future clinical settings, healthcare 330 
providers should consider their use for treatment purposes. 331 
 332 
5. Conclusion 333 
Aromatherapy massage can be considered an efficient therapy for alleviating anxiety, depression and physiological 334 
responses among older women suffering from the acute coronary syndrome. The researchers suggest that this non-335 
pharmacologic intervention can be used by clinical nurses, along with other measures, to relieve patients’ 336 
physiologic and psychological responses during the provision of care in the CCU. Adding complementary therapies 337 
in health care settings, especially the CCU, may provide an alternative for the high use of medications in the aging 338 
population. 339 
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Table 1. The demographic characteristics of the participants 520 
 521 
 522 
* P values indicated the statistical significance of differences between the intervention and control groups 523 
using the independent t-test and chi-square test.  524 
 525 
 526 
 527 
 528 
 529 
 530 
 531 
 532 
 533 
 534 
 535 
 536 
 537 
 538 
 539 
 540 
 541 
 542 
Characteristics 
 
Total 
(n = 90) 
Intervention 
group 
(n = 45) 
Control group 
(n = 45) 
Statistical test 
and 
      P value 
Age 
Mean ± SD 
 
73.300±7.801 
 
73.97±7.69 
 
72.62±7.93 
t=-0.823 
df=88 
p =0.413 
Education level, n (%) 
Illiterate 
Primary 
Diploma 
 
 
 
66(73.3) 
20(22.2) 
4(4.4) 
 
 
36(45.5) 
8(40) 
1(25) 
 
 
30(45.5) 
12(60) 
3(75) 
 
 
X2=2.345 
df=2 
p =0.310 
Marital status, n (%) 
Single 
Married  
Widow 
4(4.4) 
26(28.9) 
60(66.7) 
 
3(75) 
11(42.3) 
31(51.7) 
 
15(57.7) 
1(25) 
29(48.3) 
 
X2=1.682 
df=2 
p=0.431 
Employment status, n (%) 
Housewife 
Retired 
Disable 
 
65(72.2) 
7(7.8) 
18(20.0) 
 
32(49.2) 
3(42.9) 
10(55.6) 
 
33(50.8) 
4(57.1) 
8(44.4) 
 
X2=0.380 
df=2 
p=0.827 
Living status, n (%) 
Alone 
With spouse 
With children 
 
38(42.20 
26(28.9) 
26(28.9) 
 
18(47.4) 
12(46.2) 
15(57.7) 
 
20(52/6) 
14(53/8) 
11(42/3) 
 
X2=0.874 
df=2 
p=0.646 
History of hospitalization, n (%) 
Yes 
No 
 
60(66.7) 
30(33.3) 
 
28(46.7) 
17(56.7) 
 
32(53.3) 
13(43.3) 
 
Fisher’s exact 
p =0.503 
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Table 2. The comparison of the levels of anxiety and depression before and after the intervention  543 
*P values indicated the statistical differences between the groups using chi-squared test for the qualitative 544 
rating system of anxiety and depression. P-value reported for the quantitative rating system using t-test by 545 
considering the equality of variances.  546 
Cramer’s v2 showed the correlation between the intervention, anxiety and depression. 547 
Cohen’s d represented the effect size of the intervention on anxiety and depression, while considering 548 
their qualitative scoring systems. QRS stands for the quantitative rating system. 549 
550 
Variables Intervention 
group 
(n %) 
Control group 
  (n %) 
Statistical test and 
P value 
 
Cohens’d 
(Cramer’s v2) 
Before the intervention 
Anxiety 
Normal 
  Mild 
Moderate 
Severe               
 
 
 8(17.8) 
 8(17.8) 
13(28.9) 
16(35.6) 
 
 
11(24.4) 
11(24.4) 
 9(20.0) 
14(31.1) 
 
 
 
X2=1.808 
df=3 
 Pa=0.613 
 
 
       
QRS 
(Mean ± SD) 12.31±5.22 11.67±4.24 
Leven’s test=0.206 
t=-0.642 
df=88 
p=0.523 
 
 
Depression  
Normal  
Mild 
Moderate 
Severe 
 
 
 8(17.8 
 8(17.8 
10(22.2) 
19(42.2) 
 
 
 9(20) 
15(33.3) 
 6(13.3) 
15(33.3) 
 
 
 
X2=3.660 
df=3 
 Pa=0.301 
 
 
 
 
QRS 
(Mean ± SD) 12.51±5.40 11.71±4.29 
Leven’s test=0.122 
t=-0.778 
df=88 
p=0.439 
 
         
     After the intervention 
Anxiety          
Normal 
Mild 
Moderate 
Severe 
 
 
 
20(44.4) 
11(24.4) 
 9(20.0) 
 5(11.1) 
 
 
 
 5(11.1) 
20(44.4) 
11(24.4) 
 9(20.0) 
 
 
 
 
X2=12.956 
df=3 
 Pa=0.005 
 
 
 
 
0.75 
(0.379) 
QRS 
(Mean ± SD) 
 8.04±4.71 
 
11.07±3.19 
Leven’s test=0.032 
t=3.560 
df=77.36 
p=0.001 
 
Depression                      
Normal 
Mild 
Moderate 
Severe               
 
21(46.7) 
12(26.7) 
 8(17.8) 
 4(8.9) 
 
 4(8.9) 
19(42.2) 
12(26.7) 
10(22.2) 
 
 
X2=16.512 
df=3 
 Pa=0.001 
 
 
0.74 
(0.428) 
             
QRS 
(Mean ± SD) 8.04±4.71 11.11±3.42 
Leven’s test=0.071 
t=3.512 
df=88 
p=0.001 
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Table 3. The comparison of physiologic parameters before and after the intervention 551 
Parameter Group SBP 
Mean±SD 
DBP  
Mean± SD 
 
MAP 
Mean±SD 
 
HR 
Mean±SD 
RR  
Mean±SD 
Before 
intervention 
 
Statistical test  
P value  
 
 
Control  
Intervention  
 
 
128.42±18.83 
129.51±11.66 
 
Leven’s=0.002 
t=-0.330 
df=73.42 
p=0.743 
76.13±12.84 
80.31±9.71 
 
Leven’s=0.278 
t=-1.74 
df=88 
p=0.085 
94.33±16.34 
94.63±7.94 
 
Leven’s=0.000 
t=-0.10 
df=63.71 
p=0.913 
81.24±11.77 
76.53±11.19 
 
Leven’s=0.961 
t=1.94 
df=88 
p=0.055 
14.20±2.89 
18.00±2.34 
 
Leven’s=0.405 
t=-6.84 
df=88 
p<0.001 
After 
intervention 
 
Statistical test  
P value 
Control  
Intervention  
 
 
 
 
126.89±19.15 
118.31±10.03 
 
Leven’s=0.000 
t=2.661 
df=66.44 
p=0.010 
 
76.20±12.23 
71.19±6.50 
 
Leven’s=0.000 
t=2.42 
df=67.04 
p=0.018 
 
93.78±16.42 
85.60±7.18 
 
Leven’s=0.000 
t=3.06 
df=60.25 
p=0.003 
79.47±9.22 
74.82±11.74 
 
Leven’s=0.046 
t=2.08 
df=83.33 
p=0.040 
14.16±2.89 
16.27±2.03 
 
Leven’s=0.044 
t=-3.99 
df=78.95 
p<0.001 
Effect size 
(Cohen’s d) 
 d=0.65 
r=0.31 
d=0.54 
r=0.26 
d=0.78 
r=0.36 
d=0.41 
r=0.20 
 
* (p <0.05) 552 
Data are represented as means ± standard deviation. P-values indicated differences between the groups 553 
using the independent t-test by considering the equality of variance.  554 
Cohen’s d represented the effect size of the intervention on physiologic parameters. 555 
SBP: systolic blood pressure 556 
DBP: diastolic blood pressure 557 
MAP: mean arterial pressure 558 
HR: heart rate 559 
RR: respiratory rate 560 
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Figure 1. The process of the study based on the CONSORT flow diagram  596 
 597 
 598 
 599 
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 601 
 602 
 603 
 604 
Assessed for eligibility (n= 90) 
Excluded (n= 0) 
   Not meeting inclusion criteria (n= 0) 
   Declined to participate (n= 0) 
   Other reasons (n=0) 
Analysed (n= 45)  
 Excluded from analysis (give reasons) (n= 0) 
Lost to follow-up (give reasons) (n=0) 
Discontinued intervention (give reasons) (n= 0) 
Allocated to intervention (n= 45) 
 Received allocated intervention (n= 45) 
 Did not receive allocated intervention (give 
reasons) (n=0) 
Lost to follow-up (give reasons) (n= 0) 
Discontinued intervention (give reasons) (n=0) 
Allocated to intervention (n= 45) 
 Received allocated intervention (n=45) 
 Did not receive allocated intervention (give 
reasons) (n= 0) 
Analysed (n=45)  
 Excluded from analysis (give reasons) (n= 0) 
Allocation 
Analysis 
Follow‐Up 
Randomized (n= 90) 
Enrollment 
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